These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21181396)

  • 1. Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion.
    da Silva Xavier G; Farhan H; Kim H; Caxaria S; Johnson P; Hughes S; Bugliani M; Marselli L; Marchetti P; Birzele F; Sun G; Scharfmann R; Rutter J; Siniakowicz K; Weir G; Parker H; Reimann F; Gribble FM; Rutter GA
    Diabetologia; 2011 Apr; 54(4):819-27. PubMed ID: 21181396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per-arnt-sim (PAS) domain kinase (PASK) as a regulator of glucagon secretion.
    MacDonald PE; Rorsman P
    Diabetologia; 2011 Apr; 54(4):719-21. PubMed ID: 21327866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production.
    Semplici F; Mondragon A; Macintyre B; Madeyski-Bengston K; Persson-Kry A; Barr S; Ramne A; Marley A; McGinty J; French P; Soedling H; Yokosuka R; Gaitan J; Lang J; Migrenne-Li S; Philippe E; Herrera PL; Magnan C; da Silva Xavier G; Rutter GA
    Diabetologia; 2016 Sep; 59(9):1938-47. PubMed ID: 27338626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mutation within Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) causes basal insulin hypersecretion.
    Semplici F; Vaxillaire M; Fogarty S; Semache M; Bonnefond A; Fontés G; Philippe J; Meur G; Diraison F; Sessions RB; Rutter J; Poitout V; Froguel P; Rutter GA
    J Biol Chem; 2011 Dec; 286(51):44005-44014. PubMed ID: 22065581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells.
    Fontés G; Semache M; Hagman DK; Tremblay C; Shah R; Rhodes CJ; Rutter J; Poitout V
    Diabetes; 2009 Sep; 58(9):2048-58. PubMed ID: 19502418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Per-Arnt-Sim (PAS) kinase in the stimulation of preproinsulin and pancreatic duodenum homeobox 1 gene expression by glucose.
    da Silva Xavier G; Rutter J; Rutter GA
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8319-24. PubMed ID: 15148392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Per-Arnt-Sim kinase regulates pancreatic duodenal homeobox-1 protein stability via phosphorylation of glycogen synthase kinase 3β in pancreatic β-cells.
    Semache M; Zarrouki B; Fontés G; Fogarty S; Kikani C; Chawki MB; Rutter J; Poitout V
    J Biol Chem; 2013 Aug; 288(34):24825-33. PubMed ID: 23853095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapagliflozin Does Not Directly Affect Human α or β Cells.
    Dai C; Walker JT; Shostak A; Bouchi Y; Poffenberger G; Hart NJ; Jacobson DA; Calcutt MW; Bottino R; Greiner DL; Shultz LD; McGuinness OP; Dean ED; Powers AC
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32428240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic profiling of pancreatic alpha, beta and delta cell populations identifies delta cells as a principal target for ghrelin in mouse islets.
    Adriaenssens AE; Svendsen B; Lam BY; Yeo GS; Holst JJ; Reimann F; Gribble FM
    Diabetologia; 2016 Oct; 59(10):2156-65. PubMed ID: 27390011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells.
    Shen XX; Li HL; Pan L; Hong J; Xiao J; Hermansen K; Jeppesen PB; Li GW
    Endocr Res; 2012; 37(1):12-24. PubMed ID: 22007944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
    Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
    Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic alpha cells.
    Leclerc I; Sun G; Morris C; Fernandez-Millan E; Nyirenda M; Rutter GA
    Diabetologia; 2011 Jan; 54(1):125-34. PubMed ID: 20938634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.
    Croze ML; Flisher MF; Guillaume A; Tremblay C; Noguchi GM; Granziera S; Vivot K; Castillo VC; Campbell SA; Ghislain J; Huising MO; Poitout V
    Mol Metab; 2021 Mar; 45():101166. PubMed ID: 33484949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets.
    Yashiro H; Tsujihata Y; Takeuchi K; Hazama M; Johnson PR; Rorsman P
    J Pharmacol Exp Ther; 2012 Feb; 340(2):483-9. PubMed ID: 22106100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
    Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
    Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raldh3 expression in diabetic islets reciprocally regulates secretion of insulin and glucagon from pancreatic islets.
    Shimamura M; Karasawa H; Sakakibara S; Shinagawa A
    Biochem Biophys Res Commun; 2010 Oct; 401(1):79-84. PubMed ID: 20833146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
    Chae H; Augustin R; Gatineau E; Mayoux E; Bensellam M; Antoine N; Khattab F; Lai BK; Brusa D; Stierstorfer B; Klein H; Singh B; Ruiz L; Pieper M; Mark M; Herrera PL; Gribble FM; Reimann F; Wojtusciszyn A; Broca C; Rita N; Piemonti L; Gilon P
    Mol Metab; 2020 Dec; 42():101071. PubMed ID: 32896668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.